Jorge A. Almenara

Palmetto Hematology Oncology — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

26h-index2.7kcitations73works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Histone Deacetylase Inhibitors Research(17), Cell death mechanisms and regulation(14), Sphingolipid Metabolism and Signaling(12), Acute Myeloid Leukemia Research(11), Protein Degradation and Inhibitors(8)

Publications73 total

Analytical Validation and Clinical Utilization of the Oncomine Comprehensive Assay Plus Panel for Comprehensive Genomic Profiling in Solid Tumors
Journal of Molecular Pathology·2023· 12 citedOpen Access
Supplementary Fig. from Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions
2023Open Access
Data from Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions
2023Open Access
Supplementary Fig. from Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions
2023Open Access
Supplementary Figs S1-S15 from NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263
2023Open Access
Supplementary Information from NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263
2023Open Access
Data from Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions
2023Open Access
Data from NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263
2023Open Access
Data from NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263
2023Open Access
Supplementary Information from NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263
2023Open Access
Supplementary Figs S1-S15 from NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263
2023Open Access
Supplementary Figure 2 from Targeting Sphingosine Kinase 1 Inhibits Akt Signaling, Induces Apoptosis, and Suppresses Growth of Human Glioblastoma Cells and Xenografts
2023Open Access
Supplementary Materials, Figure Legends 1-3 from Targeting Sphingosine Kinase 1 Inhibits Akt Signaling, Induces Apoptosis, and Suppresses Growth of Human Glioblastoma Cells and Xenografts
2023Open Access
Supplementary Materials, Figure Legends 1-3 from Targeting Sphingosine Kinase 1 Inhibits Akt Signaling, Induces Apoptosis, and Suppresses Growth of Human Glioblastoma Cells and Xenografts
2023Open Access
Data from The Multikinase Inhibitor Sorafenib Potentiates TRAIL Lethality in Human Leukemia Cells in Association with Mcl-1 and cFLIP<sub>L</sub> Down-regulation
2023Open Access
Supplementary Figure 3 from Targeting Sphingosine Kinase 1 Inhibits Akt Signaling, Induces Apoptosis, and Suppresses Growth of Human Glioblastoma Cells and Xenografts
2023Open Access
Supplementary Figures 1-6 from The Multikinase Inhibitor Sorafenib Potentiates TRAIL Lethality in Human Leukemia Cells in Association with Mcl-1 and cFLIP<sub>L</sub> Down-regulation
2023Open Access
Supplementary Figure 3 from Targeting Sphingosine Kinase 1 Inhibits Akt Signaling, Induces Apoptosis, and Suppresses Growth of Human Glioblastoma Cells and Xenografts
2023Open Access
Supplementary Figure 2 from Targeting Sphingosine Kinase 1 Inhibits Akt Signaling, Induces Apoptosis, and Suppresses Growth of Human Glioblastoma Cells and Xenografts
2023Open Access
Data from Targeting Sphingosine Kinase 1 Inhibits Akt Signaling, Induces Apoptosis, and Suppresses Growth of Human Glioblastoma Cells and Xenografts
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Steven Grant(27), Paul Dent(20), Roberto R. Rosato(18), Sonia C. Maggio(8), Peter Atadja(8), Yun Dai(7), Stefanie Coe(7), Celeste N. Powers(7), Sarah Spiegel(6), Mohamed Rahmani(5), Dmitri Kapitonov(5), Tomasz Kordula(5), Sheldon Milstien(5), Jeffrey K. Adams(5), Robert E. Zipkin(5), Catherine I. Dumur(5), Jeremy C. Allegood(4), Clint Mitchell(4), Nitai C. Hait(4), Chunrong Yu(3)